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Somatic reversion events point towards RPL4 as a
novel disease gene in a condition resembling
Diamond-Blackfan anemia
Somatic revertant mosaicism is a rare phenomenon
caused by spontaneous correction of a pathogenic allele
and subsequent clonal expansion of the revertant cell. It
explains patches of healthy skin in conditions like epider-
molysis bullosa and improvement or absence of haemato-
logical conditions such as bone marrow failure in Fanconi
anemia, dyskeratosis congenita and the recently identified
syndromes caused by mutations in SAMD9 and
SAMD9L.1-5 Revertant mosaicism is restricted to condi-
tions that fulfil two prerequisites: the diseased cells have
the ability to replicate, and loss of the mutation gives these
cells a selection advantage compared to surrounding
mutated cells. Awareness of revertant mosaicism is rele-
vant to understanding variable expression of syndromes
and to understanding the absence of an expected mutation
in DNA diagnostics. 
A common cause of revertant mosaicism in dominant
disorders is mitotic recombination, resulting in a daughter
cell with two paternal copies of a chromosome segment
and one with two maternal copies. Clonal expansion of
the cells lacking the mutation relative to the mutated cells
results in mosaic segmental uniparental disomy (UPD),
which can be easily visualized in the B-allele frequency
plot of SNP arrays, even when present in a subset of the
cells.1 Acquired UPD observations can assist in disease
gene identification, as was illustrated for the condition
Ichthyosis with confetti.6
Herein, we report about a girl who was born small for
gestational age (2440 gr. at term; <-2,5SD), after an
uneventful pregnancy. She had a unilateral partial cleft lip,
low set ears and toe anomalies consisting of bilateral
shortening of the middle phalanges of the 2nd - 4th toe and
duplication of the distal phalanges of these toes (Online
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Figure 1. Acquired 15qUPD assists in the
identification of an RPL4 mutation. (A)
CytoscanHD B-allele frequency plots of chr. 15
of DNA isolated from blood samples drawn at
increasing ages and from a muscle biopsy. A
blood sample drawn at age 4 shows three
stretches of acquired mosaic UPD, with break-
points at ~64.5 Mb in 15q22.31, ~40 Mb in
15q14, and ~29.5 Mb in 15q13.1, respective-
ly (*1, *2 and *3). The samples taken at an
earlier (age 1) and later (age 9) time point
show a normal B-allele frequency pattern on
15q in the first year of life, and complete 15q
homozygosity at age 9. In muscle-derived
DNA, a normal B-allele frequency pattern is
observed.  (B) Sanger sequencing analysis of
the identified mutation in RPL4 (indicated in
the red box) in the patient and the parents (Fw
sequences). In the muscle biopsy, the muta-
tion is present in a heterozygous state. In the
blood sample drawn at age 4, the mutation is
present in a mosaic state (~20%). In the blood
sample drawn at age 9, the mutation can no
longer be identified. The sequencing analysis
showed that the mutation is absent in the
father and the mother.  (C) Schematic mRNA
sequence of the exon 2-3 boundary of wild
type (WT) and mutant (MUT) RPL4, with the
inserted nucleotides in pink. 
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Supplementary Figure S1). In her first year of life, hypotonia
and developmental delay were observed. At 11 months of
age, she was admitted to the hospital due to failure to
thrive. Hepatosplenomegaly was noted and a routine full
blood count showed mild anemia (hemoglobin 5.7 mmol/l
(normal 7.5-10.0 mmol/L), mean corpuscular volume 79
fL). A metabolic disease was suspected, for which exten-
sive metabolic testing was performed and revealed no
abnormalities. Since she showed no clinical signs of severe
anemia, hemoglobin count was never followed up and the
hepatosplenomegaly improved over time. Later in child-
hood, clinical signs of anemia were not observed, and
complete blood counts and Hb testing were not performed
anymore. The girl had a borderline intellectual disability
with attention deficit disorder and attends a special school.
At ten years of age, she had short stature (123 cm, <-
2,5SD) and unilateral hearing loss due to frequent otitis.
Informed consent for publication of clinical information
and photographs was obtained from parents. 
In search of a genomic abnormality underlying this phe-
notype, a routine diagnostic genome-wide SNP array
analysis was performed on blood and muscle derived
DNA (CytoscanHD; Life Technologies, Carlsbad, CA
92008 USA). With a genome-wide SNP array on blood
sampled at age 4, no copy number variations explaining
the phenotype of the girl were identified, but along chro-
mosome 15q towards the telomer, at least three flanking
regions with increasing imbalances in B-allele frequency
were encountered, suggestive of multiple subclonal mitot-
ic reversion events resulting in acquired mosaic
UPD15qter (Figure 1A).
We hypothesized that these clonal UPD events resulted
from a selective advantage of cells in which an as of yet
unidentified heterozygous mutation, potentially explain-
ing the symptoms in our patient, had reverted to wild
type. Indeed, SNP array analysis on blood DNA samples
taken at an earlier (age 1) and later (age 9) time point
revealed progression from a normal B-allele frequency pat-
tern on 15q in the first year of life towards complete 15q
homozygosity at nine years of age (Figure 1A). SNP array
analysis on DNA derived from a muscle biopsy taken as a
diagnostic procedure when the patient was three years old
did not show UPD15qter (Figure 1A), illustrating the tis-
sue-specificity of this phenomenon. 
The emerging 15q homozygosity in blood cells over-
lapped with the disappearing features of anemia, suggest-
ing that the region distal from the most telomeric recom-
bination breakpoint at 15q22.31 carries a genetic mutation
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Figure 2. Impaired rRNA pro-
cessing in the RPL4-mutated
patient. Agilent Bioanalyser
2100 electropherograms
obtained from total RNA of
fibroblasts taken at age 3 of the
patient carrying a RPL4 muta-
tion (A) and from a healthy con-
trol (B). The electropherogram
data demonstrated two promi-
nent peaks corresponding to
18S and 28S rRNA. Based on
the quantified peak surfaces,
we detected a reduced
28S/18S ratio (C) and
increased 32S/28S ratio (D) of
the patient compared to the
healthy control. Depicted are
the values determined in three
independent measurements.   
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with growth disadvantage in the hematopoietic system.
Whole exome sequencing was performed on muscle
derived DNA (WES; SureSelect All Exon DNA enrichment;
Solid 5500 XL sequencing). The region distal of 15q22.31
contains five OMIM genes that could possibly explain
(part of) the phenotype of the patient. However, none of
these genes carried mutations (Online Supplementary Table
S1). A search for rare coding variants with allele frequen-
cies in dbSNP and gnomAD <1% revealed four potential
candidate genes (Online Supplementary Table S2). One of
these variants was a de novo mutation (c.176-7A>G) in
RPL4 (MIM: 180479; NM_000968.3; Figure 1B), a riboso-
mal protein gene highly intolerant for mutations (ExAC
pLI score=1.00). Sanger sequencing confirmed that this
mutation was present in a full heterozygous state in mus-
cle derived DNA, subclonal (~20%) in the blood sample at
age 4, and completely absent in blood at age 9 (Figure 1B).
The variant identified had not been reported before in our
in-house database, nor in the databases ExAC, gnomAD,
GoNL or the Exome Variant Server (ESP). 
Sequencing of cDNA from fibroblast-derived RPL4 RNA
of the patient showed that the c.176-7A>G variant affects
splicing, creating a six-nucleotide insertion
(r.175_176insUUUUAG; p.(Ala58_Gly59insValLeu);
Figure 1C) in the transcript, which was not affected by
nonsense-mediated decay (NMD; Online Supplementary
Figure S2). 
The RPL4 gene encodes ribosomal protein L4. So far,
mutations in RPL4 have not been linked to human dis-
eases, but mutations in other ribosomal protein (RP) genes
cause Diamond-Blackfan anemia (DBA).7 A substantial
portion of patients with a clinical diagnosis of DBA remain
genetically unexplained.8 DBA is mainly characterized by
chronic hyporegenerative anemia, and approximately 50%
of patients with DBA have additional anomalies, including
developmental delay, short stature, cleft lip and low set
ears. These features overlap with the symptoms described
in our patient. The most frequent skeletal anomaly in DBA
are thumb defects, but anomalies of the toes as identified
in our patient have also been reported.9
Next, we studied whether this splice site mutation dis-
rupts ribosome biogenesis similar to other DBA causing RP
gene mutations. Ribosome biogenesis involves the assem-
bly of RPs and ribosomal RNAs (rRNAs), which together
comprise the structural components of the 40S and 60S
ribosomal subunits. In patients with mutated RPs of the
large ribosomal subunit (RPLs), characteristic pre-rRNA
processing signatures are found, characterized by lower
28S/18S ratios and higher residual levels of the 32S precur-
sor.10 
We analysed rRNA processing using capillary elec-
trophoresis analysis of rRNA maturation of the 40S and
60S ribosomal subunits as described before.10 Ribosomal
RNA processing analysis on our patient’s fibroblasts in
which the mutant allele is expressed, showed a reduced
28S/18S ratio and an increased 32S precursor peak com-
pared to a healthy control (Figure 2). These results suggest
an impairment of rRNA processing resulting from the
RPL4 splice site mutation in fibroblasts of our patient, sim-
ilar to what is observed for other DBA-causing RP genes.
Recently, another example of revertant mosaicism in a
patient with DBA, based on a deletion encompassing
RPS26, was reported.11 In the patient described here, we
observed three separate events of mitotic recombination
resulting in acquired mosaic UPD15q-tel. This indicates
that these events provoke a selection advantage resulting
in clonal outgrowth and replacement of RPL4 mutated
cells. Somatic reversion events in blood may occur more
frequently in DBA as, in 20% of these patients, the anemia
goes in remission.12,13 Such events hamper the identifica-
tion of mutations in blood, which may explain why muta-
tions in RPL4 have not previously been reported.8,14
In conclusion, we here report the occurrence of mitotic
recombination-based somatic reversion in a girl with a
Diamond-Blackfan anemia-like phenotype and show how
this genetic event directed us to identify RPL4 as a novel
disease-causing gene. 
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